Human Molecular Genetics Advance Access originally published online on December 15, 2004
Human Molecular Genetics 2005 14(3):429-435; doi:10.1093/hmg/ddi039
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, Vol. 14, No. 3 © Oxford University Press 2005; all rights reserved
A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes
1Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, 2Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA, 3Department of Cardiology, Children's Hospital; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA and 4Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital and Children's Hospital, Boston, MA 02115, USA
* To whom correspondence should be addressed at: Genetics Laboratory, Hematology, BWH, One Blackfan Circle, 6th Floor, Room 216, Boston, MA 02115, USA. Tel: +1 6173559005; Fax: +1 6173559016; Email: dk{at}rics.bwh.harvard.edu
Received September 24, 2004; Revised November 29, 2004; Accepted December 6, 2004
Tuberous sclerosis is a hamartoma syndrome due to mutations in TSC1 or TSC2 in which cardiac rhabdomyomas are seen in 
60% of patients. These lesions have an unusual natural history as they are usually most prominent immediately after birth and spontaneously resolve in most cases. To develop a mouse model of this lesion, we used a conditional, floxed allele of Tsc1 and a modified myosin light chain 2v allele in which cre recombinase expression occurs in ventricular myocytes. Mice with ventricular loss of Tsc1 had a median survival of 6 months and developed a dilated cardiomyopathy with the occurrence of scattered foci of enlarged ventricular myocytes. The enlarged cells were periodic acid-Schiff positive indicating the presence of excess glycogen and expressed elevated levels of phospho-S6, similar to findings in patient rhabdomyoma cells. The observations confirm that rhabdomyomas occur through a two hit mechanism of pathogenesis. However, the mice showed no evidence of fetal/neonatal demise, and there was no evidence of proliferation in the lesions. We propose that these differences are due to the timing of loss of Tsc1 in the ventricular myocytes and/or the truncated gestational period in the mouse compared with humans, during which progestational hormones may accentuate the growth of patient rhabdomyomas.
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Aggarwal, R. Sachan, S. Arya, and H. Chellani Cardiac Rhabdomyoma--A Case Report J Trop Pediatr, January 21, 2010; (2010): fmp139v1 - fmp139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mori, K. Inoki, D. Opland, H. Munzberg, E. C. Villanueva, M. Faouzi, T. Ikenoue, D. J. Kwiatkowski, O. A. MacDougald, M. G. Myers Jr., et al. Critical roles for the TSC-mTOR pathway in {beta}-cell function Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1013 - E1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pollizzi, I. Malinowska-Kolodziej, C. Doughty, C. Betz, J. Ma, J. Goto, and D. J. Kwiatkowski A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles Hum. Mol. Genet., July 1, 2009; 18(13): 2378 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. A. Radi and A. Metz Canine Cardiac Rhabdomyoma Toxicol Pathol, April 1, 2009; 37(3): 348 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-J. Choi, A. Di Nardo, I. Kramvis, L. Meikle, D. J. Kwiatkowski, M. Sahin, and X. He Tuberous sclerosis complex proteins control axon formation Genes & Dev., September 15, 2008; 22(18): 2485 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Meikle, K. Pollizzi, A. Egnor, I. Kramvis, H. Lane, M. Sahin, and D. J. Kwiatkowski Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function J. Neurosci., May 21, 2008; 28(21): 5422 - 5432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Li, F. Takeuchi, J.-a. Wang, Q. Fan, T. Komurasaki, E. M. Billings, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas PNAS, March 4, 2008; 105(9): 3539 - 3544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Meikle, D. M. Talos, H. Onda, K. Pollizzi, A. Rotenberg, M. Sahin, F. E. Jensen, and D. J. Kwiatkowski A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival J. Neurosci., May 23, 2007; 27(21): 5546 - 5558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jozwiak, K. Kotulska, J. Kasprzyk-Obara, D. Domanska-Pakiela, M. Tomyn-Drabik, P. Roberts, and D. Kwiatkowski Clinical and Genotype Studies of Cardiac Tumors in 154 Patients With Tuberous Sclerosis Complex Pediatrics, October 1, 2006; 118(4): e1146 - e1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Luo, J. R. McMullen, C. L. Sobkiw, L. Zhang, A. L. Dorfman, M. C. Sherwood, M. N. Logsdon, J. W. Horner, R. A. DePinho, S. Izumo, et al. Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy Mol. Cell. Biol., November 1, 2005; 25(21): 9491 - 9502. [Abstract] [Full Text] [PDF]
|
|